Human IgG Quick test strip |
|||
E411A02-10 | EnoGene | 10 tests | EUR 150 |
Human IgG antibody Laboratories manufactures the rt-pcr sarscov2 test uk reagents distributed by Genprice. The Rt-Pcr Sarscov2 Test Uk reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Rt-Pcr products are available in stock. Specificity: Rt-Pcr Category: Sarscov2 Group: Test Uk
TOX (Toxoplasma Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of TOX (Toxoplasma Antibody IgG) |
ANA (Antinuclear Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of ANA (Antinuclear Antibody IgG) |
Micro test tubes 3810X PCR clean |
||
Scientific Laboratory Supplies | PK1000 | EUR 49.2 |
HPV (Human Papilloma Virus Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of HPV (Human Papilloma Virus Antibody IgG) |
HDV-IgG hepatitis D IgG ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of HDV-IgG hepatitis D IgG |
zika IgG/IgM Test Card |
||
Innovation Biotech | 4.0mm (strip in a card) 25cards/box | EUR 3.6 |
Chikungunya IgG/IgM Test Card |
||
Innovation Biotech | 4.0mm (strip in a card) 25cards/box | EUR 0.7 |
SARS-CoV-2 Beta Variant Assay, 20 tests/kit |
|||
U202020-20 | USTAR Biotechnologies (Hangzhou) | test | Ask for price |
SARS-CoV-2 Alpha Variant Assay, 20 tests/kit |
|||
U202018-20 | USTAR Biotechnologies (Hangzhou) | test | Ask for price |
SARS-CoV-2 Delta Variant Assay, 20 tests/kit |
|||
U202019-20 | USTAR Biotechnologies (Hangzhou) | test | Ask for price |
SARS-CoV-2/Delta Variant Assay, 20 tests/kit |
|||
U202024-20 | USTAR Biotechnologies (Hangzhou) | test | Ask for price |
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide |
|||
9359P | ProSci | 0.05 mg | EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide |
SARS-CoV-2 Omicron Variant Assay, 20 tests/kit |
|||
U202023-20 | USTAR Biotechnologies (Hangzhou) | test | Ask for price |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 100ug) |
|||
BSV-COV-PR-79 | BioServUK | 100 ug | Ask for price |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 100ug) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 1mg) |
|||
BSV-COV-PR-86 | BioServUK | 1 mg | Ask for price |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 1mg) |
SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 10mg) |
|||
BSV-COV-PR-87 | BioServUK | 10 mg | Ask for price |
Description: SARS-CoV-2 full-length Trimeric Spike Antigen (UK/Nigerian Variant, 10mg) |
SARS-CoV-2-IgM/IgG-Test-Kit(Immunochromatographic-Assay) |
|||
EGIVD008 | EnoGene | CE-recogniton-IVD | EUR 350 |
Description: CE recogniton IVD |
SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y) Recombinant Protein |
|||
11-064 | ProSci | 0.1 mg | EUR 714.3 |
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y) Recombinant Protein |
|||
11-069 | ProSci | 0.1 mg | EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) Spike S1 (N501Y) Recombinant Protein |
|||
11-084 | ProSci | 0.1 mg | EUR 651.3 |
Description: A new variant of SARS-CoV-2 is spreading in the UK and is rapidly becoming a global threat. It ischaracterized by multiple mutations in the spike protein. Among them, N501Y is of major concernbecause it involves one of the six key amino acid residues determining a tight interaction of theSARS-CoV-2 receptor-binding domain (RBD) with its cellular receptor angiotensin-converting enzyme2 (ACE2). |
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike RBD Recombinant Protein |
|||
21-824 | ProSci | 0.1 mg | EUR 1186.8 |
Description: All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. To help the science combat these mutants ProSci offers the RB-Domains of these mutant SPIKE proteins. That is the full RBD domain of the SPIKE surface protein SARS-CoV-2 of the mutant strain B.1.1.7, also commonly known as the "UK / Great Britain mutant". |
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein |
|||
21-808 | ProSci | 50 ug | EUR 619.8 |
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells. Recently, a more transmissible variant of SARS-CoV-2, called B.1.1.7, was detected in the south of England. This variant carries a mutation in the RBD at the position 501 (N501Y). |
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein |
|||
21-811 | ProSci | 50 ug | EUR 537.9 |
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells. Recently, a more transmissible variant of SARS-CoV-2, called B.1.1.7, was detected in the south of England. This variant carries a mutation in the RBD at the position 501 (N501Y).The SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (B.1.1.7 Variant, UK) can be used as antigen in Serological ELISA Kits to detect anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma. |
OPSN00004-100UG - SARS-CoV-2 Spike RBD N501Y (UK Variant Alpha) Recombinant Protein |
|||
OPSN00004-100UG | Aviva Systems Biology | 100ug | EUR 370 |